Revance Therapeutics Inc (RVNC)

[DewDiligence]

Pending stimulus bill includes FDA money that can be used to reduce backlog of plant inspections:

https://endpts.com/stimulus-bill-packs-a-windfall-for-fda-and-covid-19-drug-vaccine-developers/

The package…will provide the FDA with $500 million to continue its quick evaluations of Covid-19 vaccines, therapeutics and diagnostics. The agency also may use the new funds to help with its backlogged inspections, to oversee and potentially prevent drug shortages caused by the pandemic, and — an ongoing pet project of acting FDA commissioner Janet Woodcock — aid in the development of continuous manufacturing.